MALDI-TOF and cluster-TOF-SIMS imaging of Fabry disease biomarkers
暂无分享,去创建一个
[1] D. Touboul,et al. Structural analysis of secondary ions by post-source decay in time-of-flight secondary ion mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[2] Kees Jalink,et al. Gold-enhanced biomolecular surface imaging of cells and tissue by SIMS and MALDI mass spectrometry. , 2006, Analytical chemistry.
[3] David Touboul,et al. Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source , 2005, Journal of the American Society for Mass Spectrometry.
[4] Jonathan V Sweedler,et al. Vitamin E imaging and localization in the neuronal membrane. , 2005, Journal of the American Chemical Society.
[5] D. Touboul,et al. Biological tissue imaging with time-of-flight secondary ion mass spectrometry and cluster ion sources. , 2005, Journal of mass spectrometry : JMS.
[6] K. Mills,et al. Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry. , 2005, Molecular genetics and metabolism.
[7] F. Halgand,et al. Lipid imaging by gold cluster time-of-flight secondary ion mass spectrometry: application to Duchenne muscular dystrophy Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M500058-JLR200 , 2005, Journal of Lipid Research.
[8] Sandrine Roy,et al. Fast fingerprinting by MALDI–TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease , 2005, Analytical and bioanalytical chemistry.
[9] B. Plecko,et al. Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry using stearoyl-d35-globotriaosylceramide as internal standard. , 2005, Rapid communications in mass spectrometry : RCM.
[10] Sander R Piersma,et al. Subcellular imaging mass spectrometry of brain tissue. , 2005, Journal of mass spectrometry : JMS.
[11] A. Altelaar,et al. Direct molecular imaging of Lymnaea stagnalis nervous tissue at subcellular spatial resolution by mass spectrometry. , 2005, Analytical chemistry.
[12] M. Simionescu,et al. Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction , 2005, Journal of cellular and molecular medicine.
[13] R. Schiffmann,et al. Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: An arterial spin tagging study , 2004, Journal of magnetic resonance imaging : JMRI.
[14] A. Das,et al. Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. , 2004, Molecular genetics and metabolism.
[15] J. Lausmaa,et al. Surface chemical analysis of carbohydrate materials used for chromatography media by time-of-flight secondary ion mass spectrometry. , 2004, Analytical chemistry.
[16] A. Mehta,et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey , 2004, European journal of clinical investigation.
[17] F. Halgand,et al. Tissue molecular ion imaging by gold cluster ion bombardment. , 2004, Analytical chemistry.
[18] Dean Billheimer,et al. Integrating histology and imaging mass spectrometry. , 2004, Analytical chemistry.
[19] Yuko Higashi,et al. Cholesterol sulfate in human physiology: what's it all about? , 2003, Journal of lipid research.
[20] Michelle L. Reyzer,et al. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. , 2003, Journal of mass spectrometry : JMS.
[21] Nicholas Lockyer,et al. A C60 primary ion beam system for time of flight secondary ion mass spectrometry: its development and secondary ion yield characteristics. , 2003, Analytical chemistry.
[22] S. Packman,et al. Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy , 2003, Annals of Internal Medicine.
[23] R. Dwek,et al. Glucosylceramide modulates membrane traffic along the endocytic pathway Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200232-JLR200 , 2002, Journal of Lipid Research.
[24] G. Bartolucci,et al. Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease. , 2002, Rapid communications in mass spectrometry : RCM.
[25] R. Desnick,et al. Fabry Disease: Twenty Novel α-Galactosidase A Mutations and Genotype-Phenotype Correlations in Classical and Variant Phenotypes , 2002, Molecular medicine.
[26] K. Mills,et al. Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry , 2002, FEBS letters.
[27] R. Bateman,et al. Ionization and fragmentation of neutral and acidic glycosphingolipids with a Q-TOF mass spectrometer fitted with a MALDI ion source , 2001, Journal of the American Society for Mass Spectrometry.
[28] M. Gladwin,et al. Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy , 2001, Circulation.
[29] P. Chaurand,et al. Organic ion imaging of biological tissue with secondary ion mass spectrometry and matrix-assisted laser desorption/ionization. , 2001, Journal of mass spectrometry : JMS.
[30] M. Stoeckli,et al. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.
[31] K. Simons,et al. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. , 2000, Trends in cell biology.
[32] N. Huh,et al. Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: a review. , 2000, Mutation research.
[33] V. Puri,et al. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases , 1999, Nature Cell Biology.
[34] M. Patterson,et al. Broad screening test for sphingolipid-storage diseases , 1999, The Lancet.
[35] R. Caprioli,et al. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.
[36] G. Fields,et al. Promotion of Fibroblast Adhesion by Triple-helical Peptide Models of Type I Collagen-derived Sequences (*) , 1996, The Journal of Biological Chemistry.
[37] D. Wink,et al. Modulation of Superoxide-dependent Oxidation and Hydroxylation Reactions by Nitric Oxide (*) , 1996, The Journal of Biological Chemistry.
[38] B. Halliwell,et al. Nitric oxide and oxygen radicals: a question of balance , 1995, FEBS letters.
[39] S. Della-Negra,et al. Impact of slow gold clusters on various solids: nonlinear effects in secondary ion emission , 1991 .
[40] Koichi Tanaka,et al. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry , 1988 .
[41] M. Karas,et al. Matrix-assisted ultraviolet laser desorption of non-volatile compounds , 1987 .
[42] T. Igarashi,et al. Effect of vitamin E and ticlopidine on platelet aggregation in Fabry's disease , 1987, Clinical genetics.
[43] R. McCluer,et al. Fabry disease , 1982, Neurology.
[44] M. Breimer,et al. Negative electrospray ionization mass spectrometry analysis of gangliosides, sulphatides and cholesterol 3‐sulphate , 1995 .
[45] Jeanette Adams,et al. Structure-specific collision-induced fragmentations of ceramides cationized with alkali-metal ions , 1993 .
[46] C. Costello,et al. Tandem mass spectrometry of glycolipids. , 1990, Methods in enzymology.
[47] A. Benninghoven,et al. Tandem Mass Spectrometer for Secondary Ion Studies , 1971 .